Clinical Trial Update: Lofexidine for Opiate Withdrawal - 1 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of lofexidine for opiate withdrawal sponsored by NIDA has completed. The study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• LOFEXIDINE (LOFEXIDINE)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Opioid-Related Disorders | Phase 3 | Status: COMPLETED